help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2003-1188
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stanojevic, V.
Right arrow Articles by Thomas, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stanojevic, V.
Right arrow Articles by Thomas, M. K.
Endocrinology Vol. 145, No. 6 2918-2928
Copyright © 2004 by The Endocrine Society

Pancreas Duodenum Homeobox-1 Transcriptional Activation Requires Interactions with p300

Violeta Stanojevic, Joel F. Habener and Melissa K. Thomas

Laboratory of Molecular Endocrinology (V.S., J.F.H., M.K.T.) and Diabetes Unit (M.K.T.), Massachusetts General Hospital, Howard Hughes Medical Institute (V.S., J.F.H.), and Harvard Medical School (J.F.H., M.K.T.), Boston, Massachusetts 02114

Address all correspondence and requests for reprints to: Melissa K. Thomas, M.D., Ph.D., Laboratory of Molecular Endocrinology and Diabetes Unit, Massachusetts General Hospital, Wellman 340, 50 Blossom Street, Boston, Massachusetts 02114. E-mail: mthomas1{at}partners.org.

The homeodomain transcription factor, pancreas duodenum homeobox (PDX)-1, is essential for pancreas development, insulin production, and glucose homeostasis. Mutations in pdx-1(ipf-1) are associated both with maturity-onset diabetes of the young and type 2 diabetes. PDX-1 interacts with multiple transcription factors and coregulators, including the coactivator p300, to activate the transcription of the insulin gene and other target genes within pancreatic ß-cells. In characterizing the protein-protein interactions of PDX-1 and p300, we identified mutations in PDX-1 that disrupt its function and are associated with increased or decreased interactions with p300. Several mutant PDX-1 proteins that are associated with heritable forms of diabetes in humans, in particular the mutant P63fsdelC, exhibited increased binding to a carboxy-terminal segment of p300 in the setting of decreased DNA-binding activities, suggesting that sequestration of p300 by mutant PDX-1 proteins may be an additional mechanism by which insulin gene expression is reduced in heterozygous carriers of pdx-1(ipf-1) mutations. The introduction of the point mutations S66A/Y68A in the highly conserved amino-terminal PDX-1 transactivation domain reduced the ability of PDX-1 to interact with p300, substantially diminished the transcriptional activation of PDX-1, and reduced the synergistic activation of glucose-responsive insulin promoter enhancer sequences by PDX-1, E12, and E47. We propose that interactions of PDX-1 with p300 are required for the transcriptional activation of PDX-1 target genes. Impairment of interactions between PDX-1 and p300 in pancreatic ß-cells may limit insulin production and lead to the development of diabetes.




This article has been cited by other articles:


Home page
EndocrinologyHome page
M.-J. Boucher, M. Simoneau, and H. Edlund
The Homeodomain-Interacting Protein Kinase 2 Regulates Insulin Promoter Factor-1/Pancreatic Duodenal Homeobox-1 Transcriptional Activity
Endocrinology, January 1, 2009; 150(1): 87 - 97.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
H.-W. Wang, M. Muguira, W.-D. Liu, T. Zhang, C. Chen, R. Aucoin, M. B Breslin, and M. S Lan
Identification of an INSM1-binding site in the insulin promoter: negative regulation of the insulin gene transcription
J. Endocrinol., July 1, 2008; 198(1): 29 - 39.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Chen, H.-X. Yan, J. Chen, W. Yang, Q. Liu, B. Zhai, H.-F. Cao, S.-Q. Liu, M.-C. Wu, and H.-Y. Wang
Negative Regulation of c-Myc Transcription by Pancreas Duodenum Homeobox-1
Endocrinology, May 1, 2007; 148(5): 2168 - 2180.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Eto, V. Kaur, and M. K. Thomas
Regulation of Pancreas Duodenum Homeobox-1 Expression by Early Growth Response-1
J. Biol. Chem., March 2, 2007; 282(9): 5973 - 5983.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. B. Deramaudt, M. M. Sachdeva, M. P. Wescott, Y. Chen, D. A. Stoffers, and A. K. Rustgi
The PDX1 Homeodomain Transcription Factor Negatively Regulates the Pancreatic Ductal Cell-specific Keratin 19 Promoter
J. Biol. Chem., December 15, 2006; 281(50): 38385 - 38395.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. W. Hay and K. Docherty
Comparative Analysis of Insulin Gene Promoters: Implications for Diabetes Research
Diabetes, December 1, 2006; 55(12): 3201 - 3213.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Mirasierra and M. Vallejo
The Homeoprotein Alx3 Expressed in Pancreatic ss-Cells Regulates Insulin Gene Transcription by Interacting with the Basic Helix-Loop-Helix Protein E47
Mol. Endocrinol., November 1, 2006; 20(11): 2876 - 2889.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-J. Boucher, L. Selander, L. Carlsson, and H. Edlund
Phosphorylation Marks IPF1/PDX1 Protein for Degradation by Glycogen Synthase Kinase 3-dependent Mechanisms
J. Biol. Chem., March 10, 2006; 281(10): 6395 - 6403.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. L. Volinic, J. H. Lee, K. Eto, V. Kaur, and M. K. Thomas
Overexpression of the Coactivator Bridge-1 Results in Insulin Deficiency and Diabetes
Mol. Endocrinol., January 1, 2006; 20(1): 167 - 182.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
J. H Lee, J. L Volinic, C. Banz, K.-M. Yao, and M. K Thomas
Interactions with p300 enhance transcriptional activation by the PDZ-domain coactivator Bridge-1
J. Endocrinol., November 1, 2005; 187(2): 283 - 292.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Iype, J. Francis, J. C. Garmey, J. C. Schisler, R. Nesher, G. C. Weir, T. C. Becker, C. B. Newgard, S. C. Griffen, and R. G. Mirmira
Mechanism of insulin Gene Regulation by the Pancreatic Transcription Factor Pdx-1: APPLICATION OF PRE-mRNA ANALYSIS AND CHROMATIN IMMUNOPRECIPITATION TO ASSESS FORMATION OF FUNCTIONAL TRANSCRIPTIONAL COMPLEXES
J. Biol. Chem., April 29, 2005; 280(17): 16798 - 16807.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Kaneto, T.-a. Matsuoka, Y. Nakatani, T. Miyatsuka, M. Matsuhisa, M. Hori, and Y. Yamasaki
A Crucial Role of MafA as a Novel Therapeutic Target for Diabetes
J. Biol. Chem., April 15, 2005; 280(15): 15047 - 15052.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Brissova, M. Blaha, C. Spear, W. Nicholson, A. Radhika, M. Shiota, M. J. Charron, C. V. E. Wright, and A. C. Powers
Reduced PDX-1 expression impairs islet response to insulin resistance and worsens glucose homeostasis
Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E707 - E714.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society